This page contains all information relating to implementation of the OECD Anti-Bribery Convention in the Slovak Republic.
Competition delegates discussed in June 2014 the financing of roll-out of broadband networks and examined alternative ways in which governments are ensuring the deployment of the infrastructure necessary to ensure high speed broadband access across their territory. Read more about the discussion.
Following previous work on concessions and procurement, this hearing that we will have in December 2014 will focus on auction and tender design and implementation to ensure an efficient outcome, including the appropriate incentives for concession holders to provide high quality and cost-efficient services and to invest in the assets. Read more
ASEAN-OECD Investment Programme fosters dialogue and experience sharing between OECD members and ASEAN member states to enhance the investment climate in the region.
English, PDF, 2,527kb
A collapse in international investment flows in Europe may be a canary in the coal mine for the region's economy: Guest commentary by Michael Gestrin of the OECD in the US and European editions of Bloomberg Brief on 11 November 2014.
English, PDF, 1,045kb
Global FDI flows collapsed with the global financial crisis in 2008 and remain 40% below pre-crisis levels. A major reason for this is the EU. While FDI flows in the rest of the world recovered by 2010, the EU continues to struggle due to structural factors that are undermining the quality of the EU’s investment environment. The paper analyses why and puts forward policy options. It is part of the Investment Insights series.
English, PDF, 669kb
This is a consolidated report covering investment measures taken between 16 February and 15 September 2014. The present report was prepared for the Freedom of Investment Roundtable 21 held on 14 October 2014.
Pharmaceuticals are special products due to special characteristics in supply and demand. Their distribution is heavily regulated to ensure that drugs are accessible, affordable, and safely consumed. Competition can and should play a role in ensuring that the pharmaceuticals distribution market works well for consumers. The 2014 Global Forum on Competition addressed competition issues in the distribution of pharmaceuticals.